TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Memphasys Ltd ( (AU:MEM) ) has issued an update.
Memphasys Ltd has announced a proposed issue of securities, including 93,379,088 NRRI options and 373,516,350 ordinary fully paid shares, as part of a standard pro rata issue. This move is expected to impact the company’s financial structure and may influence its market positioning by potentially increasing capital for further development and expansion, thereby affecting stakeholders’ interests.
More about Memphasys Ltd
Memphasys Ltd is a company that operates in the biotechnology industry, focusing on developing and commercializing innovative medical devices and technologies. The company primarily targets reproductive health and fertility solutions, aiming to enhance outcomes in assisted reproductive treatments.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.93M
See more data about MEM stock on TipRanks’ Stock Analysis page.